LFVN (STOCKS)
Lifevantage Corporation Common Stock (Delaware)
$6.350100
-2.699900 (-29.83%)
Prev close: $9.050000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Other
- CEO
- Michael A. Beindorff
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $83.26M
- Employees
- 238
- P/E (TTM)
- 20.34
- P/B (TTM)
- 3.42
- Dividend Yield
- 198.90%
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $195.32M |
| Benefits Costs and Expenses | $188.56M |
| Cost Of Revenue | $42.70M |
| Costs And Expenses | $188.56M |
| Gross Profit | $152.62M |
| Nonoperating Income/Loss | $185.00K |
| Operating Expenses | $146.04M |
| Selling, General, and Administrative Expenses | $63.22M |
| Research and Development | $1.20M |
| Other Operating Expenses | $81.61M |
| Operating Income/Loss | $6.58M |
| Income/Loss From Continuing Operations After Tax | $5.75M |
| Income/Loss From Continuing Operations Before Tax | $6.77M |
| Income Tax Expense/Benefit | $1.02M |
| Income Tax Expense/Benefit, Deferred | $2.15M |
| Net Income/Loss | $5.75M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $5.75M |
| Net Income/Loss Available To Common Stockholders, Basic | $5.75M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $0.46 |
| Diluted Earnings Per Share | $0.45 |
| Basic Average Shares | 25,169,000 |
| Diluted Average Shares | 25,511,000 |
| Common Stock Dividends | $0.18 |
| Assets | $62.13M |
| Current Assets | $39.31M |
| Inventory | $18.38M |
| Other Current Assets | $20.93M |
| Noncurrent Assets | $22.81M |
| Fixed Assets | $6.85M |
| Intangible Assets | $3.19M |
| Other Non-current Assets | $12.78M |
| Liabilities | $28.79M |
| Current Liabilities | $20.10M |
| Accounts Payable | $5.15M |
| Other Current Liabilities | $14.95M |
| Noncurrent Liabilities | $8.69M |
| Equity | $33.34M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $33.34M |
| Liabilities And Equity | $62.13M |
| Net Cash Flow From Operating Activities | $6.51M |
| Net Cash Flow From Operating Activities, Continuing | $6.51M |
| Net Cash Flow From Investing Activities | -$6.48M |
| Net Cash Flow From Investing Activities, Continuing | -$6.48M |
| Net Cash Flow From Financing Activities | -$9.88M |
| Net Cash Flow From Financing Activities, Continuing | -$9.88M |
| Exchange Gains/Losses | -$142.00K |
| Net Cash Flow | -$9.99M |
| Net Cash Flow, Continuing | -$9.84M |
| Comprehensive Income/Loss | $5.57M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $5.57M |
| Other Comprehensive Income/Loss | -$4.24M |